Active Ingredient History
Simeticone (INN), also known as simethicone (USAN), is an anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abortion, Induced (Phase 3)
Allergy and Immunology (Phase 4)
Anemia (Phase 4)
Anemia, Iron-Deficiency (Phase 4)
Anxiety Disorders (Phase 2)
Back Pain (Phase 2)
Bleeding Time (Phase 1/Phase 2)
Blepharitis (Phase 3)
Blindness (Phase 4)
Blood Loss, Surgical (Phase 3)
Burns (Phase 2/Phase 3)
Cardiovascular Diseases (Phase 1/Phase 2)
Cataract (Phase 4)
Chlamydia Infections (Phase 3)
Cognition (Phase 2/Phase 3)
Cognition Disorders (Phase 2)
Conjunctivitis (Phase 2)
Conjunctivitis, Viral (Phase 2/Phase 3)
Conscious Sedation (Phase 4)
Constipation (Phase 2)
Contact Lenses (Phase 3)
Contraception (Phase 2)
COVID-19 (Phase 1/Phase 2)
Delayed Emergence from Anesthesia (Phase 2)
Delirium (Phase 2)
Depression (Phase 2)
Dermatitis, Atopic (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2)
Dietary Fiber (Phase 1)
Dry Eye Syndromes (Phase 4)
Extensively Drug-Resistant Tuberculosis (Phase 1/Phase 2)
Fatty Liver (Phase 1/Phase 2)
Gastroenteritis (Phase 2/Phase 3)
Gastroesophageal Reflux (Phase 2)
General Surgery (Phase 4)
Geriatrics (Phase 2/Phase 3)
Glaucoma (Phase 4)
Glioblastoma (Phase 1/Phase 2)
Gonorrhea (Phase 3)
Healthy Volunteers (Phase 1)
HIV Infections (Phase 3)
HIV Seropositivity (Phase 4)
Hypercholesterolemia (Phase 4)
Hyperkalemia (Phase 4)
Hypertension (Phase 2)
Inflammation (Phase 4)
Intestinal Neoplasms (Phase 4)
Intestines (Phase 4)
Irritable Bowel Syndrome (Phase 2)
Keratoconjunctivitis Sicca (Phase 4)
Lewy Body Disease (Phase 1)
Liver Cirrhosis (Phase 1/Phase 2)
Macular Edema (Phase 2)
Metabolic Syndrome (Phase 2/Phase 3)
Microbiota (Phase 1)
Mitochondrial Diseases (Phase 2)
Morphine (Phase 4)
Myopia (Phase 4)
Nails (Phase 2)
Neurocognitive Disorders (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 1/Phase 2)
Obesity (Phase 2)
Osteoarthritis (Phase 3)
Osteoarthritis, Hip (Phase 2)
Osteoarthritis, Knee (Phase 2)
Overweight (Phase 2/Phase 3)
Oxidative Stress (Phase 1/Phase 2)
Pain (Phase 4)
Peripheral Arterial Disease (Phase 2)
Prostatic Neoplasms (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Respiratory Tract Infections (Phase 3)
Retinal Detachment (Phase 4)
Retinopathy of Prematurity (Phase 4)
Schizophrenia (Phase 2)
Sleep Apnea, Obstructive (Early Phase 1)
Stomach Diseases (Early Phase 1)
Tears (Phase 4)
Tuberculosis, Multidrug-Resistant (Phase 1/Phase 2)
Xerophthalmia (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
